specific laws stating whom one can and cannot marry. The Babylonian Talmud compiled approximately 1500 years ago is an extremely rich source for the description of a number of human genetic malformations and syndromes.' For example, various cranial, facial, and body malformations are mentioned in Kodashim, tractate Bekhorot 44a, familial epilepsy is described in Nashim, tractate Yevamot 64b, and in the same tractate and page one can find a report of haemophilia. The testicular feminisation syndrome can be recognised from the writing and discussion found in Nashim, tractate Ketuboth 10b, and a clinical description of Marfan's syndrome is mentioned in Kodashim, tractate Bekhorot 45b. Analysis of the Talmud for genetic malformations and syndromes is in its infancy and in the years to come such studies should prove most rewarding.
With a long Jewish tradition of critical thinking about all matters pertaining to life, coupled with the newly emerging interest in human genetics, it was not surprising that the modern State of Israel, established in 1948, would find itself actively engaged in a variety of human genetic studies. The main impetus for this initial flourish of activity came from the massive number of Jewish immigrants arriving in Israel from all parts of the world. Israel immediately became the ideal setting for studying genetic similarities and differences among the Jewish people. In addition to investigating genetic polymorphisms among the various Jewish communities, Israeli physicians and geneticists also found themselves absorbed in learning about such inherited diseases as familial Mediterranean fever, Dubin-Johnson syndrome, G6PD deficiency, thalassaemia, and phenylketonuria to mention just a few.
Although several medical centres and institutions soon became interested in the practical and investigative aspects of genetic diseases and polymorph-179 isms among the Jewish people, two centres in particular achieved international recognition for their pioneering work in these areas. The Hadassah University Hospital and the Hebrew University in Jerusalem under the guidance of the late Professor Elizabeth Goldschmidt, and the former TelHashomer Hospital (now the Chaim Sheba Medical Centre) and the Tel-Aviv University under the inspiration and thinking of the late Professor Chaim Sheba became the leading medical genetic centres in Israel.
Israel and its people
Israel is a very small country, approximately 280 miles (450 km) in length and 110 miles (180 km) at maximum width. The majority of its total population of approximately 5 million people is clustered in the centre of the country. Seventy-five percent of its land is desert. The population can be divided into Jewish (4.3 million) and non-Jewish (700 000), mainly Arab-Moslems. The Jewish population can similarly be grouped into three major ethnic groups.2 The oldest are the Oriental Jews (originating from the continent of Asia), followed by the Sephardi Jews (originating from countries of the Mediterranean basin), which together comprise 53% of the Jewish Israeli population. The youngest of the groups, the Ashkenazi Jews (originating from central and eastern Europe), make up the remaining 47% of the Jewish population. This almost equal distribution between non-Ashkenazi (Oriental plus Sephardi Jews) and Ashkenazi Jews makes the Israeli scene an ideal place to study all genetic aspects of the Jewish people.
Human population genetics
The initial stimulus for genetic studies among the various Jewish ethnic groups in Israel was the immigration in the early 1950s of over a million Jewish immigrants making 'aliyah' (literally: coming to Israel from over 100 countries in all continents). It was soon recognised that frequencies of genetic diseases differed markedly among the various communities, an observation which further served as a catalyst for studying the 'genetic profiles' of these populations.3 4 It therefore seems fitting that this report begins with Israeli studies in population genetics. The questions asked initially were essentially those that are being asked today by Israeli population geneticists regarding the Jewish people.
(1) How heterogeneous are each of the communities?
(2) How much do they differ genetically from each other and from their previous host population? (3) 
Cytogenetics
The basis for the development of human cytogenetics in Israel was the group created at the Hebrew University in Jerusalem by Professor Jacob Wahrman. His experience in mammalian cytogenetics17 has been extremely important in the studies of one more mammal, namely Homo sapiens, at the cytogenetic level. In February 1958, the first human material was obtained. This was testicular tissue which yielded meiotic cells of good quality. The development of methods for processing peripheral blood for chromosome studies of mitotic cells enabled the start of cytogenetic studies for medical purposes and contributed to the role of chromosome aberrations in the aetiology of congenital malformation syndromes.'20
With the increasing demand for cytogenetic studies it became necessary to provide for the training of professional staff with a background in genetics, cytology, and cell biology. A number of graduates, from the Department of Genetics in Jerusalem, has contributed to the further growth and spread of human cytogenetics all over the country.
Since the early 1960s other medical centres have begun human cytogenetic studies and today 10 laboratories are actively engaged in studies using peripheral blood for clinical cases and bone marrow and solid tumours in malignancies. Prenatal cytogenetics using amniotic cells is performed in five centres, while chorionic villus placental and cord blood sampling are performed in selected centres.
Areas of special scientific interest in human cytogenetics include the chromosome breakage syn- 21 22 drome ataxia telangiectasia. A new class of chromosome bands, 'D bands', has been defined on the basis of the sensitivity of human chromosomes to DNAse I. This work27 has been done in the laboratory of the late Menashe Marcus.
Analysis of chromosomal aberrations is now entering a new era; molecular analysis using specific probes for chromosome markers (for example, alphoid probes for specific centromeres, Y chromosome specific sequences) will be applied in the Department of Human Genetics, Hadassah Medical Centre in Jerusalem as well as in the Sackler School of Medicine in Tel-Aviv. It is hoped that with these new methods, coupled with the wealth of clinical material, we shall continue to contribute to the advancement of human cytogenetics.
Biochemical genetics
The study of lysosomal storage disorders in various ethnic groups in Israel shows the unique structure of Israeli society and illustrates some unusual findings in certain Israeli communities which will be outlined here.
The Israel is characterised by the existence of genetic isolates in Jewish and Arabic communities. These communities are also characterised by a high degree of consanguinity. As expected in these cases a relatively high frequency of genetic disorders is common in each community, but unexpected lysosomal storage disorders comprise a large proportion of the recessive disorders, while these disorders are relatively rare in the general population. The fact that these disorders can be tested biochemically and heterozygotes can usually be unambiguously identified enabled us to conduct screening programmes to assess the frequency of the mutant gene in some of these communities and to identify heterozygous couples and offer them prenatal diagnosis. These programmes have caused a dramatic decrease in the birth of affected children. Two examples are illustrated below.
( 42 The work described here illustrates the importance of biochemical evaluation of genetic disorders as a powerful tool in preventive medicine. We shall therefore focus our future endeavours in these areas. This should be achieved by identifying the biochemical defect in those genetic disorders where the defect is not characterised as yet, mainly those disorders found in relatively high frequency in specific communities in Israel, such as familial dysautonomia in the Ashkenazi Jews, or albinism and mental retardation in certain Arabic communities. This should lead to the development of reliable assay techniques for unambiguous diagnosis of patients, heterozygotes, and affected fetuses before initiating mass screening in the relevant population.
Molecular genetics
The use of molecular probes for diagnostic purposes began in Israel in 1981, when a group of molecular biologists at the Medical School of the Hebrew University of Jerusalem and the Department of Haematology at the Hadassah Medical Centre joined forces to introduce the first prenatal diagnosis of thalassaemia and sickle cell anaemia in Israel using globin probes. Since 1985, five additional laboratories in Jerusalem, the Tel-Aviv area, and Beersheva have initiated the use of molecular probes for prenatal diagnosis of cystic fibrosis, Duchenne muscular dystrophy, haemophilia, phenylketonuria, and 21-hydroxylase deficiency, and are preparing for routine diagnosis of the fragile X syndrome, adult polycystic kidney disease, Huntington's disease, and neurofibromatosis.
Molecular cytogenetics, that is, the analysis of chromosomal aberrations with molecular probes, is in its infancy at the Medical School of Tel-Aviv University. An extensive repository of X chromosome and autosomal probes has been established for this purpose.
Since the medical genetics community in Israel is small, the periodic meetings of the Israeli Society of Medical Genetics enable all the members of this community to learn about the progress being made in each laboratory.
Basic This study was the precursor of others on various Jewish groups and a number of isolates such as the Samaritans, Habbanites, the Falasha, and Indian Jews. [59] [60] [61] Because genetic distance between Jewish Israeli populations of different geographical extraction is similar, investigative studies have confirmed that selected dermatoglyphic traits are suitable for calculating interpopulation distance coefficients.9 62 Moreover it has been shown that the similarity between different Jewish groups conformed to the findings in diverse Caucasian samples, confirming the discriminating possibilities of palmar dermatoglyphics related to the main human races.
In the 1960s it became clear that patients with certain autosomal and sex chromosomal syndromes (for example, Down's syndrome, XO, XXY, etc) had distinct and characteristic dermatoglyphic patterns. These changes were also noted in fetuses terminated between the 20th and 24th week of gestation.63 In addition our studies in Israel showed that these typical dermatoglyphic patterns were superimposed on the existing dermatoglyphic differences between Jews and non-Jews.' 5 We investigated dermatoglyphic patterns in specific Jewish genetic diseases, like Tay-Sachs disease and familial dysautonomia, plus other inborn errors of metabolism, but did not find any distinct features. On the other hand, we have shown that in some genetic syndromes involving the hands (such as TelHashomer camptodactyly66) and wrinkly skin syndrome67 distinct and even diagnostic changes are present.
An extensive study on the biological significance of two kinds of dermatoglyphic asymmetry, directional and fluctuating, is being performed at TelAviv University. Directional asymmetry can be regarded as a developmentally controlled trait presumably having a genetic basis, while fluctuating asymmetry is thought to result from the inability of the fetus to buffer various stress factors during embryogenesis. There is preliminary evidence to suggest that males are biologically less The Israeli genetic community has been stimulated, not only by its plethora of material but also by the current advances being made in all phases of human genetic studies, to continue to increase its knowledge of genetic diseases and population differences and similarities, and also to improve the care of all its people who suffer from genetic diseases. A brief account of our current activities has been presented in this review. Just as few would have predicted 40 years ago the scientific advances that have taken place in the sphere of human genetics, so we shall be surprised as to the tremendous progress that will be made in the next 40 years that will result in better health for all mankind.
